<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02038140</url>
  </required_header>
  <id_info>
    <org_study_id>CSU2011-07E</org_study_id>
    <nct_id>NCT02038140</nct_id>
  </id_info>
  <brief_title>Zimmer Trabecular Metal Total Ankle PMCF</brief_title>
  <official_title>Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer® Trabecular Metal™ Total Ankle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to obtain implant survivorship and clinical outcome&#xD;
      data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary&#xD;
      or revision total ankle arthroplasty. The assessment will include implant survivorship and&#xD;
      clinical performance measured by pain and function, quality of life data, radiographic&#xD;
      parameters and survivorship.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a prospective, multicenter, study of the commercially available Zimmer&#xD;
      Trabecular Metal Ankle semiconstrained implants. The study will require each site to obtain&#xD;
      Institutional Review Board approval prior to study enrollment. All potential study subjects&#xD;
      will be required to participate in the Informed Consent Process.&#xD;
&#xD;
      All study subjects will undergo preoperative clinical evaluations prior to their primary or&#xD;
      revision total ankle arthroplasty. The post-operative clinical and radiographic evaluations&#xD;
      will be conducted at 6 weeks, 6 month, 1 year, 2, 3, 5, 7, and 10 years. Follow-up surveys&#xD;
      will occur at 4, 6, 8, and 9 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2027</completion_date>
  <primary_completion_date type="Anticipated">March 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship</measure>
    <time_frame>10 years</time_frame>
    <description>Survival of the implants after 10 years which is based on removal of the prosthesis and will be determined using the Kaplan Meier Method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Orthopaedic Foot and Ankle Society Score</measure>
    <time_frame>First 2 years</time_frame>
    <description>Performance os the Zimmer Trabecular Metal Ankle after 2 years which is assessed by the AOFAS score.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Degenerative Arthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Post Traumatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Zimmer TM Total Ankle System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Primary or revision total ankle arthroplasty subjects that receive the Zimmer Trabecular Metal Total Ankle System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zimmer Trabecular Metal Total Ankle System</intervention_name>
    <description>Primary or revision total ankle replacement</description>
    <arm_group_label>Zimmer TM Total Ankle System</arm_group_label>
    <other_name>Primary Ankle Replacement</other_name>
    <other_name>Total Ankle Arthroplasty</other_name>
    <other_name>Total Ankle Replacement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is &gt; 18 years of age&#xD;
&#xD;
          -  The patient is skeletally mature&#xD;
&#xD;
          -  The patient qualifies for primary or revision total ankle replacement based on&#xD;
             physical exam and medical history including the following: degenerative arthritis,&#xD;
             rheumatoid arthritis, post-traumatic arthritis.&#xD;
&#xD;
          -  The patient is willing and able to provide written informed consent&#xD;
&#xD;
          -  Patient is willing and able to cooperate in the required post-operative therapy&#xD;
&#xD;
          -  The patient is willing and able to complete scheduled follow-up evaluations&#xD;
             questionnaires as described in the Informed Consent&#xD;
&#xD;
          -  The patient has participated in the Informed Consent process and has signed the&#xD;
             Institutional Review Board/European Commission approved Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is: a prisoner, mentally incompetent or unable to understand what&#xD;
             participation in the study entails, a known alcohol or drug abuser, anticipated to be&#xD;
             non-compliant.&#xD;
&#xD;
          -  The patient has one of the following compromising the affected limb: ankle arthrodesis&#xD;
             with malleolar exeresis, severe neurological or vascular disease, loss of musculature&#xD;
             or neuromuscular compromise, severe instability, maltracking or misalignment of the&#xD;
             tibia and talus uncorrectable by surgery.&#xD;
&#xD;
          -  The patient has a local/systemic infection that may affect the prosthetic joint&#xD;
&#xD;
          -  The patient has a previous history of infection in the affected joint&#xD;
&#xD;
          -  The patient is known to be pregnant&#xD;
&#xD;
          -  The patient has insufficient bone stock or bone quality to fix the components (i.e.&#xD;
             osteoporosis, Charcot's disease)&#xD;
&#xD;
          -  The patient has a known sensitivity or allergic reaction to one or more of the&#xD;
             implanted materials&#xD;
&#xD;
          -  The patient is unwilling or unable to give consent or to comply with the follow-up&#xD;
             program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold, RN MBA</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University California Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Associates of Grand Rapids REI</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina Research Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705-4677</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UBC Providence Health Care Research Institute</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital Finland</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikverbund St. Antonius und St. Josef GmbH</name>
      <address>
        <city>Wuppertal</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Humanitas San Pio X</name>
      <address>
        <city>Milan</city>
        <state>Milano MI</state>
        <zip>20159</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital-Stiftung Universitatsspital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spital StS AG</name>
      <address>
        <city>Thun</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 14, 2014</study_first_submitted>
  <study_first_submitted_qc>January 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2014</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Ankle Replacement</keyword>
  <keyword>Total Ankle Arthroplasty</keyword>
  <keyword>Total Ankle Replacement</keyword>
  <keyword>Trabecular Metal Total Ankle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

